Lmr Partners LLP Prothena Corp Public LTD CO Transaction History
Lmr Partners LLP
- $9.66 Billion
- Q4 2024
A detailed history of Lmr Partners LLP transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Lmr Partners LLP holds 18,000 shares of PRTA stock, worth $236,520. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,000Holding current value
$236,520% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PRTA
# of Institutions
197Shares Held
39.3MCall Options Held
601KPut Options Held
259K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$152 Million7.5% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$50.7 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.69MShares$48.4 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$29.4 Million0.44% of portfolio
-
State Street Corp Boston, MA1.86MShares$24.5 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $617M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...